Sign In
Buy TBPH
$15.92
+0.340 (+2.18%)
At Close: Jun 03, 2026
Theravance Biopharma: Q4 Earnings Insights
04:45pm, Tuesday, 23'rd Feb 2021
Shares of Theravance Biopharma (NASDAQ:TBPH) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 21.37% over the past year to ($0.92), wh
Theravance Biopharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021
06:00am, Tuesday, 09'th Feb 2021
DUBLIN, Feb. 9, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-s
Theravance Biopharma To Present at the 39th Annual J.P. Morgan Healthcare Conference
06:00am, Tuesday, 05'th Jan 2021
DUBLIN, Jan. 5, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-
Theravance Biopharma Is A Buy
01:16pm, Wednesday, 02'nd Dec 2020
Today, we revisit Theravance Biopharma for the first time in over a year. The stock has had a challenging year in 2020, but there are some potentially significant catalysts on the horizon in 2021.
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
01:24pm, Sunday, 08'th Nov 2020
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2020 Results - Earnings Call Transcript
